Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
Please note the ANZCTR will be unattended on Monday the 7th of October for the Labour Day public holiday.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12617000038392
Ethics application status
Approved
Date submitted
23/12/2016
Date registered
10/01/2017
Date last updated
16/02/2018
Type of registration
Prospectively registered
Titles & IDs
Public title
Feasibility of a pedometer guided physical activity intervention in limiting weight gain in pregnant obese women (The Fit MUM feasibility study)
Query!
Scientific title
Feasibility of a pedometer guided physical activity intervention in limiting weight gain in pregnant obese women (The Fit MUM feasibility study)
Query!
Secondary ID [1]
290805
0
Nil known
Query!
Universal Trial Number (UTN)
U1111-1184-1167
Query!
Trial acronym
The Fit MUM feasibility study
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Obesity
Antenatal care
301456
0
Query!
Obesity
301457
0
Query!
Condition category
Condition code
Reproductive Health and Childbirth
301231
301231
0
0
Query!
Antenatal care
Query!
Diet and Nutrition
301232
301232
0
0
Query!
Obesity
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Thirty obese pregnant women (body mass index greater than or equal to 30 kg/m2 at first clinic booking ) aged 18 years or over, will be supplied with the Fitbit Zip (registered trademark) pedometer and wear it on a daily basis during waking hours until final antenatal visit. Women will be randomised into three groups of 10:
1. Control Group: will wear the pedometer, blinded to daily step counts.
2. Intervention Group A, Pedometer feedback only: will have pedometer “synched” to their personal smartphone, with ability to self-monitor daily step counts.
3. Intervention Group B, Pedometer feedback + behavior change: will have an added behavior change program in addition to pedometer feedback, with additional regular support from study investigators.
Participants in groups 2 and 3 will be encouraged to increase their physical activity levels in line with the Australian Physical Activity guidelines for adults, aiming for at least 30 minutes of moderate physical activity most days of the week (or 150 minutes per week). The Fitbit pedometer registers this level of physical activity as “fairly” or “very” active and equates to approximately 10,000 steps per day.
Intervention Group B: In addition to written resources and synching of pedometer data, patients will receive an intervention involving a face-to-face session with a health coach, with follow up telephone and monthly mobile phone text messages (SMS) throughout the intervention until delivery, to remind participants to practice the new behaviours, as used in previous trials. This is based on the successful “HeLP-her” intervention. This intervention is based on self-determination and cognitive behavioural theory, with motivational interviewing the primary method of interaction with participants. The aim will be to support and empower pregnant women to optimise their weight gain during pregnancy. The sessions will progressively educate women about the importance of healthy eating and physical activity during pregnancy, the balance between energy intake and energy expenditure, removing common misconceptions about exercise in pregnancy, increasing confidence about exercise and optimising daily healthy food choices and physical activity throughout pregnancy. Intervention content is underpinned by key components of the behavioural theory including skills of goal setting, action planning and self-monitoring all of which are important factors in long-term behavioural change. The sessions will be interactive and involve practising skills in behaviour change in the form of action planning, removing barriers, identifying enablers, self-monitoring and social persuasion. They will be encouraged to weigh themselves regularly as self-monitoring has been shown through past trials to significantly limit gestational weight gain when coupled with lifestyle intervention. Participants will first attend a one-on-one initial 30 minute assessment session at baseline (16 weeks), followed by one facilitator-led interactive small group session of 60 minutes between 16 and 20 weeks gestation held in the antenatal clinic at Sunshine Hospital. The facilitator will be a trained health coach, trained in the HeLP-her intervention by the developers of the tool at Monash University. Using the topics presented in Session 1 as a guide, participants will be assisted by the facilitator to generate goals and action plans based on their personal priorities, thereby developing a personalised gestational weight gain strategy. At gestational weeks 20 and 24 they will receive a 20 minute telephone coaching session delivered by staff trained in motivational interviewing, which utilise client-orientated counselling to explore and resolve ambivalence and review progress, provide encouragement and assistance and to ensure skills are practiced and action plans are completed. By 28 weeks of pregnancy, participants will have received one face-to-face interactive session, one group intervention and 2 telephone coaching sessions.
Query!
Intervention code [1]
296727
0
Behaviour
Query!
Intervention code [2]
296728
0
Prevention
Query!
Intervention code [3]
296766
0
Treatment: Devices
Query!
Comparator / control treatment
Masked pedometers will be supplied to the control group to record baseline steps, with written resources provided including the Australian Physical Activity and Sedentary Behaviour Guidelines, the guidelines on pregnancy and exercise published by Physical Activity Australia, and dietary guidelines for Australian Adults. Brief general physical activity advice framed around these guidelines will be provided at baseline.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
300596
0
Specific (composite) feasibility outcomes
1. Willingness of participants to be recruited (recruitment rate)
2. Maintenance of blinding of control group to pedometer step count (concealment of pedometer display with tamper proof tape)
3. Patient compliance with wearing pedometers, and synching data regularly
4. Patient follow up to study conclusion, with minimal dropout rate
5. Target population recruitment feasibility (number of potential participants attending antenatal clinic)
6. Data integrity and completeness of uploaded step counts to investigators
7. Estimate of standard deviation of main outcome measures (excessive gestational weight gain, step count) to further inform definitive trial sample size
Query!
Assessment method [1]
300596
0
Query!
Timepoint [1]
300596
0
At study conclusion
Query!
Secondary outcome [1]
330486
0
Daily step count
Query!
Assessment method [1]
330486
0
Query!
Timepoint [1]
330486
0
At study conclusion
Query!
Secondary outcome [2]
330487
0
Daily minutes at each activity level
Query!
Assessment method [2]
330487
0
Query!
Timepoint [2]
330487
0
At study conclusion
Query!
Eligibility
Key inclusion criteria
1. Pregnant woman aged 18 years or over
2. Body mass index greater than or equal to 30 kg/m2 at baseline (gestational week 12-15)
3. Recruitment below 20 weeks gestation
4. No mobility impairment (ie. able to ambulate normally without gait aids)
5. Availability of a smartphone capable of allowing Fitbit data uploading (eg. Apple iPhone (registered trademark) or Android (registered trademark) operating system equipped phone).
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Joint or muscle disorder sufficient to impair walking to a target of 10,000 steps daily.
2. Pre-eclampsia diagnosis
3. Twin or multiple pregnancy
4. Preterm rupture of membranes
5. Incompetent cervix/cerclage
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Blinded envelope technique
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomised from a computer generated list
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Continuous data (such as step count, minutes at each activity level) will be tested for normality. Normally distributed data will be summarised using mean and standard deviation and will be compared between the three groups using one-way analysis of variance. Non-normally distributed data will be summarised with median (range/IQR) and will be compared using the Kruskal-Wallis test. Categorical data will be summarised using number (count) and differences across groups assessed using Chi-squared tests. Potential confounders of the association between excessive weight gain, activity levels/step counts and group allocation will be explored using multivariate logistic regression. These potential confounding variables may include age, weight, height, parity, country of birth, household income and educational background, as these have been previously shown to influence activity levels in pregnancy
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
6/02/2017
Query!
Actual
6/03/2017
Query!
Date of last participant enrolment
Anticipated
2/10/2017
Query!
Actual
15/05/2017
Query!
Date of last data collection
Anticipated
2/10/2017
Query!
Actual
1/12/2017
Query!
Sample size
Target
30
Query!
Accrual to date
Query!
Final
30
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
7177
0
Sunshine Hospital - St Albans
Query!
Recruitment postcode(s) [1]
14938
0
3021 - St Albans
Query!
Funding & Sponsors
Funding source category [1]
295231
0
Hospital
Query!
Name [1]
295231
0
Department of Anaesthesia and Pain Medicine, Sunshine Hospital
Query!
Address [1]
295231
0
Department of Anaesthesia and Pain Medicine
Sunshine Hospital
Furlong Road
St Albans VIC 3021
Query!
Country [1]
295231
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Department of Anaesthesia and Pain Medicine, Sunshine Hospital
Query!
Address
Department of Anaesthesia and Pain Medicine
Sunshine Hospital
Furlong Road
St Albans VIC 3021
Query!
Country
Australia
Query!
Secondary sponsor category [1]
294059
0
None
Query!
Name [1]
294059
0
Query!
Address [1]
294059
0
Query!
Country [1]
294059
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
296572
0
Melbourne Health
Query!
Ethics committee address [1]
296572
0
Office for Research The Royal Melbourne Hospital Level 2 South West 300 Grattan Street Parkville VIC 3050 Australi
Query!
Ethics committee country [1]
296572
0
Australia
Query!
Date submitted for ethics approval [1]
296572
0
26/09/2016
Query!
Approval date [1]
296572
0
20/12/2016
Query!
Ethics approval number [1]
296572
0
HREC/16/MH/320
Query!
Summary
Brief summary
The aim of this study is to determine the feasibility of implementing a pedometer intervention to reduce the incidence of excessive gestational weight gain in pregnant obese women in a cost effective, reliable manner. The results from this feasibility trial will help guide a future large, multicentre randomised trial. In detail, we aim to: 1. Refine and test the trial protocol for a follow-on large multicentre trial; 2. Examine efficacy in increasing activity level to a target of 150 minutes of “fairly active” or “very active” time per week in pregnant obese women via feedback from the Fitbit Zip (registered trademark) pedometer in line with Australian National Physical Activity Guidelines for adults; 3. Examine efficacy in increasing step count at least 150% from baseline measurements (up to 10,000 steps) via feedback from the Fitbit Zip (registered trademark) pedometer; 4. Evaluate the impact of investigator feedback compared with participant self-monitoring alone, on the reduction in excessive gestational weight gain of pregnant obese participants; 5. Confirm earlier trial results, in healthy volunteers, in assessing acceptability of the trial protocol and pedometer use to our patients and antenatal staff, as a high recruitment and participation rate will be required for a viable definitive study; 6. Determine retention rates over the trial period (as dropouts over participants’ pregnancies will significantly limit a future RCT); 7. Assess the magnitude of any effect of the interventions (with particular respect to reducing the incidence of excessive gestational weight gain, and increasing activity and step count levels) to further inform sample size calculation for a definitive trial. Study Outline Thirty obese pregnant women (body mass index greater than or equal to 30 kg/m2 at first clinic booking ) aged 18 years or over, will be supplied with the Fitbit Zip (registered trademark) pedometer and wear it on a daily basis during waking hours until final antenatal visit. Women will be randomised into three groups of 10: 1. Control Group: will wear the pedometer, blinded to daily step counts. 2. Intervention Group A, Pedometer feedback only: will have pedometer “synched” to their personal smartphone, with ability to self-monitor daily step counts. 3. Intervention Group B, Pedometer feedback + behavior change: will have an added behavior change program in addition to pedometer feedback, with additional regular support from study investigators. Participants in groups 2 and 3 will be encouraged to increase their physical activity levels in line with the Australian Physical Activity guidelines for adults, aiming for at least 30 minutes of moderate physical activity most days of the week (or 150 minutes per week). The Fitbit pedometer registers this level of physical activity as “fairly” or “very” active and equates to approximately 10,000 steps per day.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
66594
0
Dr Jai Darvall
Query!
Address
66594
0
Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
300 Grattan St
Parkville VIC 3050
Query!
Country
66594
0
Australia
Query!
Phone
66594
0
+61 3 9342 7136
Query!
Fax
66594
0
Query!
Email
66594
0
jai.darvall@mh.org.au
Query!
Contact person for public queries
Name
66595
0
Jai Darvall
Query!
Address
66595
0
Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
300 Grattan St
Parkville VIC 3050
Query!
Country
66595
0
Australia
Query!
Phone
66595
0
+61 3 9342 7136
Query!
Fax
66595
0
Query!
Email
66595
0
jai.darvall@mh.org.au
Query!
Contact person for scientific queries
Name
66596
0
Jai Darvall
Query!
Address
66596
0
Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
300 Grattan St
Parkville VIC 3050
Query!
Country
66596
0
Australia
Query!
Phone
66596
0
+61 3 9342 7136
Query!
Fax
66596
0
Query!
Email
66596
0
jai.darvall@mh.org.au
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
A Pedometer-Guided Physical Activity Intervention for Obese Pregnant Women (the Fit MUM Study): Randomized Feasibility Study.
2020
https://dx.doi.org/10.2196/15112
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF